#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adenoid cystic carcinoma Univentricular heart Osteomyelitis Spinal cord injury cervical Choroid melanoma Cytomegalovirus infection Thrombocytopenia Basal cell naevus syndrome Sarcoma Acquired ATTR amyloidosis Juvenile idiopathic arthritis Interstitial lung disease Chronic kidney disease Oesophageal adenocarcinoma stage II Thrombotic microangiopathy More trials…

    Learn about Rare Diseases

    Nephrotic syndrome – Diagnostics Stevens-Johnson syndrome – Life with Disease Congenital nephrogenic diabetes insipidus – Basic Information Ornithine transcarbamoylase deficiency – Trials in Disease Leukoencephalopathy – Basic Information Sjogren’s syndrome Hepatoblastoma – Basic Information KBG syndrome – Diagnostics Progressive supranuclear palsy – Life with Disease Turner’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Eftilagimod Alfa LUMC-BOB1-B7-TCR.1 Bictegravir Lixisenatide Bepranemab OMEGA-3-ACID ETHYL ESTERS 90 Zagociguat Pacritinib PEGZILARGINASE LTX-002 SODIUM Vancomycin Hydrochloride Midazolam Hydrochloride Quizartinib Dihydrochloride Dextrose Bp Oxybuprocaine Iti-1284 Sirolimus Hydroxocobalamin Minzasolmin Haloperidol Decanoate More therapies…

    Learn about Your Condition

    Glanzmann's disease Erythema migrans Arthritis infective Post cardiac arrest syndrome Lymphangiosarcoma Follicular lymphoma stage IV Hidradenitis Peripheral artery thrombosis Mucopolysaccharidosis Hepatic neoplasm Ichthyosis Lymphocyte adoptive therapy Pelizaeus-Merzbacher disease White matter lesion Peritoneal dialysis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of apremilast compared to placebo in children aged 5-17 years with juvenile psoriatic arthritis

    Recruiting

    3 1
    Investigated Drugs:
    • Apremilast
    Austria Belgium France Germany Greece Italy +6

  • Study on Chiropractic Therapy and Ibuprofen for Acute Neck Pain in Adults

    Recruiting

    3 1 1
    Investigated Diseases:
    • Neck pain
    Investigated Drugs:
    • Lactose
    • Ibuprofen
    Norway

  • Study on the Effectiveness of Rituximab and Drug Combination for Patients with High-Risk Aggressive B-Cell Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Lymphoma
    Investigated Drugs:
    • Doxorubicin Hydrochloride
    • Methotrexate
    • Cyclophosphamide
    Sweden

  • Study Comparing Medroxyprogesterone Acetate and Ganirelix for Women Undergoing Fertility Treatment with Embryo Accumulation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility female
    Investigated Drugs:
    • Ganirelix
    • Medroxyprogesterone Acetate
    Spain

  • Study on the Effects of Morphine Sulfate for Relieving Breathlessness and Cough in Patients with Fibrotic Interstitial Lung Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • Morphine Sulfate
    • Placebo
    Denmark

  • Study on the Effects of Semaglutide, Dapagliflozin, and Metformin in Patients with Coronary Artery Disease and Prediabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Arteriosclerosis coronary artery
    • Glucose tolerance impaired
    • Coronary artery disease
    Investigated Drugs:
    • Metformin Hydrochloride
    • Dapagliflozin
    • Semaglutide
    Poland
Previous Page
1 … 445 446 447 448 449 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!